Cheryl Meguid

592 total citations
29 papers, 323 citations indexed

About

Cheryl Meguid is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Cheryl Meguid has authored 29 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 11 papers in Cancer Research and 9 papers in Surgery. Recurrent topics in Cheryl Meguid's work include Pancreatic and Hepatic Oncology Research (20 papers), Cancer Genomics and Diagnostics (11 papers) and Renal cell carcinoma treatment (6 papers). Cheryl Meguid is often cited by papers focused on Pancreatic and Hepatic Oncology Research (20 papers), Cancer Genomics and Diagnostics (11 papers) and Renal cell carcinoma treatment (6 papers). Cheryl Meguid collaborates with scholars based in United States, Japan and Sweden. Cheryl Meguid's co-authors include Richard D. Schulick, Martin D. McCarter, Barish H. Edil, Csaba Gajdos, Brandon C. Chapman, Ana Gleisner, Alessandro Paniccia, Tracey E. Schefter, Marco Del Chiaro and Joshua T. Byers and has published in prestigious journals such as Journal of Clinical Oncology, British journal of surgery and Medicine.

In The Last Decade

Cheryl Meguid

25 papers receiving 319 citations

Peers

Countries citing papers authored by Cheryl Meguid

Since Specialization

Citations

This map shows the geographic impact of Cheryl Meguid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Meguid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Meguid more than expected).

Fields of papers citing papers by Cheryl Meguid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Meguid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Meguid. The network helps show where Cheryl Meguid may publish in the future.

Co-authorship network of co-authors of Cheryl Meguid

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Meguid. A scholar is included among the top collaborators of Cheryl Meguid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Meguid. Cheryl Meguid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploration of Patient Retention in Seeking a Second Opinion: A Retrospective Cohort Study 2024 ·Journal of Surgical Research ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Anne-Lise D. D’Angelo, (unknown), (unknown), (unknown), Ana Gleisner, Cheryl Meguid, Richard D. Schulick, (unknown), (unknown)	0
2	Dynamic Anthropometrics in Pancreatic Cancer: Associations Between Body Composition Changes During Neoadjuvant Therapy and Survival Outcomes After Resection 2024 ·Annals of Surgical Oncology ·(unknown), Robert J. Torphy, (unknown), Cheryl Meguid, Oskar Franklin, (unknown), Salvador Rodriguez Franco, (unknown), (unknown), Steven A. Ahrendt, Richard D. Schulick, Marco Del Chiaro, (unknown)	0
3	ASO Visual Abstract: Dynamic Anthropometrics in Pancreatic Cancer—Associations Between Body Composition Changes During Neoadjuvant Therapy and Survival Outcomes After Resection 2024 ·Annals of Surgical Oncology ·(unknown), Robert J. Torphy, (unknown), Cheryl Meguid, Oskar Franklin, (unknown), Salvador Rodriguez Franco, (unknown), (unknown), Steven A. Ahrendt, Richard D. Schulick, Marco Del Chiaro, Martin D. McCarter	1
4	The future is now: Implementation of standard of care, preemptive pharmacogenomic testing in patients with gastrointestinal cancers. 2024 ·Journal of Clinical Oncology ·(unknown), James Martin, Kristy Crooks, Casey S. Greene, (unknown), Natalie M. Johnson, David Kao, Nicholas Rafaels, (unknown), Cheryl Meguid, (unknown), S. Lindsey Davis, Christopher H. Lieu, Christina L. Aquilante	1
5	Comparison of Invasive Pancreatic Ductal Adenocarcinoma versus Intraductal Papillary Mucinous Neoplasm: A National Cancer Database Analysis 2023 ·Cancers ·Ioannis A. Ziogas, Salvador Rodriguez Franco, (unknown), Cheryl Meguid, (unknown), Mohammed Al-Musawi, Sophoclis P. Alexopoulos, Richard D. Schulick, Marco Del Chiaro	13
6	Pulmonary metastasectomy is associated with survival after lung-only recurrence in pancreatic cancer 2023 ·Surgery ·Christina M. Stuart, Michael J. Kirsch, (unknown), Cheryl Meguid, Toshitaka Sugawara, Kathryn Colborn, Wells A. Messersmith, Christopher H. Lieu, Ana Gleisner, Marco Del Chiaro, Richard D. Schulick, Robert A. Meguid	7
7	Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis 2022 ·British journal of surgery ·Atsushi Oba, Yan‐Dong Wu, Kathryn Colborn, Sana D. Karam, Cheryl Meguid, Mohammed Al-Musawi, Quoc Riccardo Bao, Ana Gleisner, Steven A. Ahrendt, Richard D. Schulick, Marco Del Chiaro	17
8	Ductal Dilatation of ≥5 mm in Intraductal Papillary Mucinous Neoplasm Should Trigger the Consideration for Pancreatectomy: A Meta-Analysis and Systematic Review of Resected Cases 2021 ·Cancers ·Yan‐Dong Wu, Atsushi Oba, Laurel Beaty, Kathryn Colborn, Salvador Rodriguez Franco, Ben Harnke, Cheryl Meguid, (unknown), Roberto Valente, Steven A. Ahrendt, Richard D. Schulick, Marco Del Chiaro	11
9	Selecting surgical candidates with locally advanced pancreatic cancer: a review for modern pancreatology 2021 ·Journal of Gastrointestinal Oncology ·Yan‐Dong Wu, Atsushi Oba, Ronggui Lin, Shuichi Watanabe, Cheryl Meguid, Richard D. Schulick, Marco Del Chiaro	10
10	Multifocal/diffuse pancreatic serous cystic neoplasms: Systematic review with a new case 2020 ·Pancreatology ·Yan‐Dong Wu, Jason M. Samuels, Ben Harnke, (unknown), Mohammed Al-Musawi, Cheryl Meguid, Steven A. Ahrendt, Richard D. Schulick, Marco Del Chiaro, Atsushi Oba	2
11	Impact of neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT) on R0 resection rate for borderline resectable and locally advanced pancreatic cancer 2020 ·HPB ·Sara Zakem, Adam C. Mueller, Cheryl Meguid, Robert J. Torphy, Douglas E. Holt, Tracey E. Schefter, Wells A. Messersmith, Martin D. McCarter, Marco Del Chiaro, Richard D. Schulick, Karyn A. Goodman	15
12	The role of neoadjuvant chemotherapy in elderly patients with borderline or locally advanced pancreatic cancer: Is it safe and feasible? 2020 ·Journal of Clinical Oncology ·Atsushi Oba, Christopher H. Lieu, Cheryl Meguid, S. Lindsey Davis, Alexis D. Leal, (unknown), Gentry Teng King, Karyn A. Goodman, Tracey E. Schefter, Ana Gleisner, Steven A. Ahrendt, Stephen Leong, Wells A. Messersmith, (unknown), Marco Del Chiaro	2
13	Quality of Life Following Major Laparoscopic or Open Pancreatic Resection 2019 ·Annals of Surgical Oncology ·Robert J. Torphy, Brandon C. Chapman, Chloe Friedman, Christina Nguyen, (unknown), Cheryl Meguid, Steven A. Ahrendt, Martin D. McCarter, Marco Del Chiaro, Richard D. Schulick, Barish H. Edil, Ana Gleisner	22
14	Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity‐modulated radiation therapy (IMRT) in pancreatic adenocarcinoma 2018 ·Journal of Surgical Oncology ·Brandon C. Chapman, Ana Gleisner, (unknown), Cheryl Meguid, Karyn A. Goodman, Brian Brauer, Csaba Gajdos, Richard D. Schulick, Barish H. Edil, Martin D. McCarter	15
15	Evolving Trends Towards Minimally Invasive Surgery for Solid-Pseudopapillary Neoplasms 2016 ·Annals of Surgical Oncology ·Camille L. Stewart, Cheryl Meguid, Brandon C. Chapman, Richard D. Schulick, Barish H. Edil	24
16	Multidisciplinary management for esophageal and gastric cancer 2016 ·Cancer Management and Research ·(unknown), Sachin Wani, Tracey E. Schefter, Phillip J. Koo, Cheryl Meguid, Stephen Leong, (unknown), (unknown), Martin D. McCarter	34
17	The Multidisciplinary Approach to GI Cancer Results in Change of Diagnosis and Management of Patients. Multidisciplinary Care Impacts Diagnosis and Management of Patients 2016 ·Annals of Surgical Oncology ·Cheryl Meguid, Richard D. Schulick, Tracey E. Schefter, Christopher H. Lieu, (unknown), Nicole Williams, Jon D. Vogel, Csaba Gajdos, Martin D. McCarter, Barish H. Edil	23
18	Multidisciplinary management of pancreatic adenocarcinoma with isolated pulmonary metastases. 2016 ·Journal of Clinical Oncology ·Supriya Jain, Cheryl Meguid, Stephen Leong, Barish H. Edil, Martin D. McCarter, Tracey E. Schefter, Richard D. Schulick, Christopher H. Lieu	1
19	Establishing a framework for building multidisciplinary programs 2015 ·Journal of Multidisciplinary Healthcare ·Cheryl Meguid, (unknown), Barish H. Edil, Richard D. Schulick, Csaba Gajdos, (unknown), Tracey E. Schefter, Wendy M. Purcell, Martin D. McCarter	18
20	Neoadjuvant FOLFIRINOX Application in Borderline Resectable Pancreatic Adenocarcinoma 2014 ·Medicine ·Alessandro Paniccia, Barish H. Edil, Richard D. Schulick, Joshua T. Byers, Cheryl Meguid, Csaba Gajdos, Martin D. McCarter	44

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact